Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase

Molecular Cancer Research

Volumn 7, Issue 1, 2009, Pages 108-117

  Han, Shouwei ^a   Sun, Xiaojuan ^a   Ritzenthaler, Jeffrey D ^a   Roman, Jesse ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ENZYME INHIBITOR; FISH OIL; INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SB 239023; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING;

CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; FISH OILS; GENE DELETION; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 58649105337     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0384     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician 2007;75:56-63.
3. Reddy BS, Patlolla JM, Simi B, Wang SH, Rao CV. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in ω-3 polyunsaturated fatty acids. Cancer Res 2005;65:8022-7.
4. Nowak J, Weylandt KH, Habbel P, et al. Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n -3 fatty acids. Carcinogenesis 2007;28:1991-5.
5. Hardman WE. Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. Nutr Cancer 2007;57:177 -83.
6. Sauer LA, Blask DE, Dauchy RT. Dietary factors and growth and metabolism in experimental tumors. J Nutr Biochem 2007;18:637 -49.
7. Trombetta A, Maggiora M, Martinasso G, Cotogni P, Canuto RA, Muzio G. Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung- tumor cells increasing lipid peroxidation and PPARs. Chem Biol Interact 2007; 165:239-50.
8. Kliewer SA, Willson TM. The nuclear receptor PPARγ-bigger than fat. Curr Opin Genet Dev 1998;8:576-81.
9. Chene G, Dubourdeau M, Balard P, et al. n -3 and n-6 polyunsaturated fatty acids induce the expression of COX-2 via PPARγ activation in human keratinocyte HaCaT cells. Biochim Biophys Acta 2007;1771:576 -89.
10. Schopfer FJ, Lin Y, Baker PR, et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor γ ligand. Proc Natl Acad Sci USA 2005;102:2340 -5.
11. Grommes C, Landreth GE, Heneka MT. Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists. Lancet Oncol 2004;5:419-29.
12. Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005;5:51 -63.
13. Liu J, Costello PC, Pham NA, et al. Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J Thorac Oncol 2006;1:771 -9.
14. Cordes N. Overexpression of hyperactive integrin-linked kinase leads to increased cellular radiosensitivity. Cancer Res 2004;64:5683 -92.
15. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature 1996;379:91 -6.
16. Koul D, Shen R, Bergh S, et al. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression ofhuman glioblastoma. Mol Cancer Ther 2005;4:1681 -8.
17. Yano M, Matsumura T, Senokuchi T, et al. Statins activate peroxisome
18. proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages. Circ Res 2007;100:1442 -51.
19. Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG. Activation of peroxisome proliferator-activated receptor-γ by troglitazone (TGZ) inhibits human lung cell growth. J Cell Biochem 2005;96:760 -74.
20. Han S, Zheng Y, Roman J. Rosiglitazone, an agonist of PPARγ, inhibits non- small cell carcinoma cell proliferation in part through activation oftumor sclerosis complex-2. PPAR Res 2007;2007:29632.
21. Costa V, Foti D, Paonessa F, et al. The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidi- nedione-PPARγ agonists. Endocr Relat Cancer 2008;15:325-35.
22. Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPARγ agonists: evidence for disparate functional effects which are independent of NF-κB and PPARγ. Cell Signal 2005;17:1098-110.
23. Pandey MK, Pant AB, Das M. In vitro cytotoxicity of polycyclic aromatic hydrocarbon residues arising through repeated fish fried oil in human hepatoma Hep G2 cell line. Toxicol In Vitro 2006;20:308 -16.
24. Istfan NW, Chen ZY, Rex S. Fish oil slows S phase progression and may cause upstream shift of DHFR replication origin ori-β in CHO cells. Am J Physiol Cell Physiol 2002;283:C1009 -24.
25. Cerchietti LC, Navigante AH, Castro MA. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 2007;59: 14-20.
26. Sawai H, Okada Y, Funahashi H, et al. Integrin-linked kinase activity is associated with interleukin-1α-induced progressive behavior of pancreatic cancer and poor patient survival. Oncogene 2006;25:3237 -46.
27. Imanishi Y, Hu B, Jarzynka MJ, et al. Angiopoietin-2 stimulates breast cancer metastasis through the α5β1 integrin-mediated pathway. Cancer Res 2007;67: 4254-63.
28. Okamura M, Yamaji S, Nagashima Y, et al. Prognostic value of integrin β1- ILK-pAkt signaling pathway in non-small cell lung cancer. Hum Pathol 2007;38: 1081 -91.
29. Han S, Ritzenthaler JD, Sitaraman SV, Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular- regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 2006;281:29614-24.
30. Marks JL, Gong Y, Chitale D, et al. Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma. Cancer Res 2008;68:5524-8.
31. Allred CD, Talbert DR, Southard RC, Wang X, Kilgore MW. PPARγ1asa molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 2008;138:250 -6.
32. Yee LD, Young DC, Rosol TJ, Vanbuskirk AM, Clinton SK. Dietary (n -3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARγ ligand rosiglitazone. J Nutr 2005;135:983 -8.
33. Zhang Y, Ikegami T, Honda A, et al. Involvement of integrin- linked kinase in carbon tetrachloride -induced hepatic fibrosis in rats. Hepatology 2006;44:612-22.
34. Melchior C, Kreis S, Janji B, Kieffer N. Promoter characterization and genomic organization of the gene encoding integrin-linked kinase 1. Biochim Biophys Acta 2002;1575:117 -22.
35. Schwartz B, Melnikova VO, Tellez C, et al. Loss of AP-2γ results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo . Oncogene 2007;26:4049 -58.
36. Pellikainen JM, Kosma VM. Activator protein-2 in carcinogenesis with a special reference to breast cancer-a mini review. Int J Cancer 2007;120:2061 -7.
37. Fauquette V, Aubert S, Groux-Degroote S, et al. Transcription factor AP-2α represses both the mucin MUC4 expression and pancreatic cancer cell proliferation. Carcinogenesis 2007;28:2305 -12.
38. Choi HJ, Chung TW, Kim SJ, et al. The AP-2α transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene. Glycobiology 2008;18:395 -407.
39. Han S, Ritzenthaler JD, Wingerd B, Roman J. Activation of peroxisome proliferator-activated receptor β/δ(PPARβ/δ) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3- kinase and CCAAT/enhancer-binding protein β. J Biol Chem 2005;280: 33240-9.
40. Fox PL, DiCorleto PE. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 1988;241:453-6.
41. Williams T, Tjian R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 1991;5:670-82.
42. Di-Poi N, Tan NS, Michalik L, Wahli W, Desvergne B. Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 2002;10:721 -33.
43. Han S, Sidell N, Fisher PB, Roman J. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor γ in human lung carcinoma cells. Clin Cancer Res 2004;10:1911 -9.